Comparison of Intrasinus and Extrasinus Approach for the Placement of Zygomatic Implants in Severely Resorbed Edentulous Maxillary Arch Using Zygomatic Success Code - An In-Vivo Study

Various approach has outlined in the literature but no clinical studies that have compared the intrasinus and extrasinus approach for the placement of zygomatic implants using zygomatic success code.

The present study is planned to compare the intrasinus and extrasinus approach for the placement of zygomatic implant in severely resorbed edentulous maxillary arch using zygomatic success code.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Haryana
      • Rohtak, Haryana, India, 124001
        • PGIDS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

INCLUSION CRITERIA

  • Completely edentulous maxilla.
  • Both gender without any systemic disease.
  • Patients with Misch-Type III edentulous maxillary arch and with Seibert's Class III ridge.
  • ZAGA-4 patients (pronounced buccal concavities of the maxilla).

EXCLUSION CRITERIA

  • Any systemic illness/medications
  • Radiation therapy to the head and neck region 12 months prior to the proposed therapy.
  • Smoking
  • Pregnant and lactating women
  • Drug allergy
  • Bisphosphonates medication
  • Alcohol/ drug addiction
  • Maxillary sinusitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: INTRASINUS

PARAMETERS ASSESED:

  1. IMPLANT STABILITY
  2. SINUS PATHOLOGY
  3. SOFT TISSUE CONDITIONING
  4. PROSTHETIC OFFSET 18 SAMPLES INCLUDED
CRESTAL INCISION FROM TUBEROSITY TO TUBEROSITY AND REFLECT THE FLAP . OSTEOTOMY DONE FROM MOLAR TO ZYGOMATIC BONE.IMPLANT PLACEMENT DONE
Active Comparator: EXTRASINUS

PARAMETERS ASSESED:

  1. IMPLANT STABILITY
  2. SINUS PATHOLOGY
  3. SOFT TISSUE CONDITIONING
  4. PROSTHETIC OFFSET 18 SAMPLES INCLUDED
CRESTAL INCISION FROM TUBEROSITY TO TUBEROSITY AND REFLECT THE FLAP . OSTEOTOMY DONE FROM MOLAR TO ZYGOMATIC BONE.IMPLANT PLACEMENT DONE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Zygomatic implant stability
Time Frame: Implant stability was evaluated individually after 3 and 6 months of implant placement and prosthetic rehabilitation

When extra-sinus and intra-sinus placed implants are tested individually, slight mobility should be detected with no other associated pathological signs. Instrument used for checking the implant stability is periotest.

Mobility of the implant comes from the elastic modulus of the anchoring zygomatic bone when they are bent by a remotely applied force. On the other hand, the movement must not be rotational, and it will disappear when implants are splinted together. A rotational movement should be considered as a sign of implant failure. Grade I- no mobility, no pain Grade II-light clinical mobility, no pain Grade III-clear clinical mobility, no pain (no evidence of disintegration of the apical part of the implant or rotation Grade IV- clear clinical mobility, rotation and pain evidence of disintegration of apical part of the implant)

Implant stability was evaluated individually after 3 and 6 months of implant placement and prosthetic rehabilitation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Associated sinus pathology
Time Frame: Associated sinus pathologywas assessed at 3 and 6 months after implant placement

Frequently associated complications such as rhinitis and sinusitis were assessed by two scoring systems: Lund-Mackay staging and the Lanza and Kennedy score.

Lund-Mackay stating and Lanza and Kennedy score

This system scored six sinus regions: anterior ethmoid, posterior ethmoid, maxillary sinus, frontal sinus, sphenoid sinus, and osteomeatal complex for sinus pathology. The score 0 represented no abnormality; 1 represented partial opacification; and 2 represented total opacification. For the osteomeatal complex, the score was either 0 or 2. This scoring was done for pre-operative and post-operative evaluation.

Lanza-Kennedy - Rhinosinusal Clinical Symptoms

It is patient-related questionnaire to identify the rhinosinusal clinical symptoms. Each symptom

question is answered by "yes" or "no". The diagnosis of sinusitis requires a "yes" answer in two or more major criteria, one major and two or more minor criteria, or purulence on nasal examination

Associated sinus pathologywas assessed at 3 and 6 months after implant placement
Peri-Implant Soft Tissue Condition
Time Frame: Soft tissue around the zygomatic implant was assessed at 3 and 6 months
Soft tissue around the zygomatic implant was assessed at 3 and 6 months after implant placement and prosthetic replacement, where the exposed implant surface was measured from the implant head to the soft tissue recession area.
Soft tissue around the zygomatic implant was assessed at 3 and 6 months
Prosthetic Offset
Time Frame: Prosthetic Offset assessed at 3 and 6 months

Prosthetic success depends on the anatomic measurements to assess the implant position of the head of the zygomatic implant.

Four anatomical measurements will be performed to assess the following:

  1. Perpendicular distance between the tangent to the floor of the nose and sinus floor at the entrance of the zygomatic implant level.
  2. Perpendicular distance between the tangent to the floor of the nose and the crest of the alveolar ridge at the entrance of the zygoma implant level.

    i. The height of the alveolar ridge at the location of the head of the zygomatic implant (measurement 2 minus 1)

  3. Distance between the midline of the palate and the center of the zygomatic implant head.
  4. Distance between the midline of the palate and the center of the alveolar ridge.

ii. The position of the head of the zygomatic implants with regard to the center of the crest of the alveolar ridge in the horizontal axial dimension (measurement 4 minus 3).

A positive value on this implant head position

Prosthetic Offset assessed at 3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2023

Primary Completion (Actual)

April 25, 2024

Study Completion (Actual)

December 26, 2024

Study Registration Dates

First Submitted

February 4, 2025

First Submitted That Met QC Criteria

March 1, 2026

First Posted (Actual)

March 5, 2026

Study Record Updates

Last Update Posted (Actual)

March 5, 2026

Last Update Submitted That Met QC Criteria

March 1, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Dhanavath Prabhavathi

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Implant Stability

Clinical Trials on ZYGOMATIC IMPLANT KIT

Subscribe